Low Volatility Alert VIX -7.0%
Heat Map
Below is a clickable Heat Map of the 10 symbols on this page. The percent change is based on Friday's prices.

JNJ Profile

Dow IndustrialS&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
372 Billion
Large-Cap
Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States. JNJNews

JNJ Earnings

Earnings Per Share (EPS)
0.67
Price To Earnings Ratio (P/E)
24.34
2nd Quarter Earnings Report
for Apr, May & Jun

Tue, Jul 16, 2019 (143 days ago)
Since Earnings Report +4.6%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Tue, Oct 15, 2019 (52 days ago)
Since Earnings Report +7.7%

JNJ Dividend

Annual Dividend Yield
2.70%
Annual Dividend Rate
$3.80
Ex-Dividend Date
Mon, Nov 25, 2019 (11 days ago)
Dividend Pay Date
Tue, Dec 10, 2019
Dividend Payments
2,304 Payments (Quarterly)

JNJ Charts

All Time High $148.99 Tue, Dec 4, 2018


MRK Profile

Dow IndustrialS&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
226 Billion
Large-Cap
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. Merck

MRK Earnings

Earnings Per Share (EPS)
0.74
Price To Earnings Ratio (P/E)
33.85
2nd Quarter Earnings Report
for Apr, May & Jun

Tue, Jul 30, 2019 (129 days ago)
Since Earnings Report +7.9%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Tue, Oct 29, 2019 (38 days ago)
Since Earnings Report +8.3%

MRK Dividend

Annual Dividend Yield
2.74%
Annual Dividend Rate
$2.44
Ex-Dividend Date
Fri, Dec 13, 2019
Dividend Pay Date
Wed, Jan 8, 2020
Dividend Payments
1,637 Payments (Quarterly)

MRK Charts

All Time High $96.69 Thu, Nov 30, 2000

CAR vs HTZ

PFE Profile

Dow IndustrialS&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
213 Billion
Large-Cap
Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales. pfizer

PFE Earnings

Earnings Per Share (EPS)
1.38
Price To Earnings Ratio (P/E)
11.28
2nd Quarter Earnings Report
for Apr, May & Jun

Tue, Jul 30, 2019 (129 days ago)
Since Earnings Report -7.7%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Tue, Oct 29, 2019 (38 days ago)
Since Earnings Report +2.6%

PFE Dividend

Annual Dividend Yield
3.76%
Annual Dividend Rate
$1.44
Ex-Dividend Date
Thu, Nov 7, 2019 (29 days ago)
Dividend Pay Date
Mon, Dec 2, 2019
Dividend Payments
1,632 Payments (Quarterly)

PFE Charts

All Time High $50.04 Mon, Apr 12, 1999

DG vs DLTR

BMY Profile

S&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
139 Billion
Large-Cap
Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.

BMY Earnings

Earnings Per Share (EPS)
0.83
Price To Earnings Ratio (P/E)
15.35
2nd Quarter Earnings Report
for Apr, May & Jun

Thu, Jul 25, 2019 (134 days ago)
Since Earnings Report +40.1%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Thu, Oct 31, 2019 (36 days ago)
Since Earnings Report +6.5%

BMY Dividend

Annual Dividend Yield
2.71%
Annual Dividend Rate
$1.64
Ex-Dividend Date
Thu, Oct 3, 2019 (64 days ago)
Dividend Pay Date
Fri, Nov 1, 2019
Dividend Payments
1,632 Payments (Quarterly)

BMY Charts

All Time High $77.12 Fri, Jul 15, 2016


AMGN Profile

Nasdaq 100S&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
139 Billion
Large-Cap
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine). Amgen

AMGN Earnings

Earnings Per Share (EPS)
3.29
Price To Earnings Ratio (P/E)
15.15
2nd Quarter Earnings Report
for Apr, May & Jun

Tue, Jul 30, 2019 (129 days ago)
Since Earnings Report +32.9%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Tue, Oct 29, 2019 (38 days ago)
Since Earnings Report +14.1%

AMGN Dividend

Annual Dividend Yield
2.48%
Annual Dividend Rate
$5.80
Ex-Dividend Date
Thu, Nov 14, 2019 (22 days ago)
Dividend Pay Date
Fri, Dec 6, 2019
Dividend Payments
408 Payments (Quarterly)

AMGN Charts

All Time High $235.80 Mon, Nov 25, 2019


NVO Profile

SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
132 Billion
Large-Cap
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders. novonordisk

NVO Earnings

Earnings Per Share (EPS)
4.30
Price To Earnings Ratio (P/E)
18.42
3rd Quarter Earnings Report
for Jul, Aug & Sep

Fri, Nov 1, 2019 (35 days ago)
Since Earnings Report +2.6%
4th Quarter Earnings Report
for Oct, Nov & Dec

Wed, Feb 5, 2020

NVO Dividend

Annual Dividend Yield
2.78%
Annual Dividend Rate
$1.58
Ex-Dividend Date
Fri, Mar 22, 2019 (259 days ago)
Dividend Pay Date
Tue, Apr 2, 2019
Dividend Payments
456 Payments (Biannual)

NVO Charts

All Time High $60.34 Mon, Aug 3, 2015


ABBV Profile

S&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
128 Billion
Large-Cap
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. abbvie

ABBV Earnings

Earnings Per Share (EPS)
1.27
Price To Earnings Ratio (P/E)
22.14
2nd Quarter Earnings Report
for Apr, May & Jun

Fri, Jul 26, 2019 (133 days ago)
Since Earnings Report +30.5%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Fri, Nov 1, 2019 (35 days ago)
Since Earnings Report +9.4%

ABBV Dividend

Annual Dividend Yield
5.42%
Annual Dividend Rate
$4.72
Ex-Dividend Date
Tue, Jan 14, 2020
Dividend Pay Date
Fri, Feb 14, 2020
Dividend Payments
345 Payments (Quarterly)

ABBV Charts

All Time High $125.86 Fri, Jan 26, 2018


LLY Profile

S&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
115 Billion
Large-Cap
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction. LillyPad

LLY Earnings

Earnings Per Share (EPS)
1.37
Price To Earnings Ratio (P/E)
40.60
3rd Quarter Earnings Report
for Jul, Aug & Sep

Wed, Oct 23, 2019 (44 days ago)
Since Earnings Report +9.5%
4th Quarter Earnings Report
for Oct, Nov & Dec

Thu, Jan 30, 2020

LLY Dividend

Annual Dividend Yield
2.14%
Annual Dividend Rate
$2.58
Ex-Dividend Date
Thu, Nov 14, 2019 (22 days ago)
Dividend Pay Date
Tue, Dec 10, 2019
Dividend Payments
1,632 Payments (Quarterly)

LLY Charts

All Time High $132.13 Tue, Mar 26, 2019


SNY Profile

SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
113 Billion
Large-Cap
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales. sanofi

SNY Earnings

Earnings Per Share (EPS)
0.71
Price To Earnings Ratio (P/E)
21.78
2nd Quarter Earnings Report
for Apr, May & Jun

Mon, Jul 29, 2019 (130 days ago)
Since Earnings Report +6.0%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Thu, Oct 31, 2019 (36 days ago)
Since Earnings Report +0.0%

SNY Dividend

Annual Dividend Yield
3.87%
Annual Dividend Rate
$1.74
Ex-Dividend Date
Tue, May 7, 2019 (213 days ago)
Dividend Pay Date
Fri, May 31, 2019
Dividend Payments
228 Payments (Annually)

SNY Charts

All Time High $57.42 Mon, Sep 22, 2014


GILD Profile

Nasdaq 100S&P 500
SECTOR
Health Care
INDUSTRY
Biotech & Pharma
MARKET CAPITALIZATION
85 Billion
Large-Cap
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology. GileadSciences

GILD Earnings

Earnings Per Share (EPS)
-0.92
Price To Earnings Ratio (P/E)
--
2nd Quarter Earnings Report
for Apr, May & Jun

Tue, Jul 30, 2019 (129 days ago)
Since Earnings Report -0.5%
3rd Quarter Earnings Report
for Jul, Aug & Sep

Thu, Oct 24, 2019 (43 days ago)
Since Earnings Report +1.4%

GILD Dividend

Annual Dividend Yield
3.38%
Annual Dividend Rate
$2.28
Ex-Dividend Date
Thu, Dec 13, 2018 (358 days ago)
Dividend Pay Date
Fri, Dec 28, 2018
Dividend Payments
15 Payments (Quarterly)

GILD Charts

All Time High $123.37 Wed, Jun 24, 2015

Symbol Price Day YTD
ABBV $87.01 0.3% -2.5%
AGN $186.60 0.3% 37.3%
ALXN $113.83 6.0% 16.1%
AMGN $233.78 0.2% 21.8%
BIIB $301.44 0.7% -1.1%
BMRN $80.13 0.1% -5.7%
BMY $60.05 1.0% 15.4%
CELG $108.24 0.1% 62.4%
ENDP $4.89 1.5% -36.6%
GILD $67.16 1.9% 5.9%
INCY $94.56 0.6% 48.8%
JNJ $140.45 0.6% 9.9%
LLY $119.92 0.1% 4.4%
MNK $3.38 0.0% -79.6%
MRK $88.86 0.1% 17.6%
MYL $19.29 2.1% -30.9%
PFE $38.26 0.6% -11.5%
PRGO $52.38 1.1% 29.3%
REGN $372.29 1.1% -0.0%
VRTX $222.99 -0.0% 35.9%
ZTS $121.39 1.1% 43.7%
SHPG $179.20 0.0% 3.8%
NKTR $20.43 2.9% -40.3%
SNY $44.92 1.2% 4.8%
TEVA $9.93 1.1% -37.4%
ABEO $2.85 3.3% -59.5%
ABIO $5.37 -0.9% -9.6%
ABUS $2.27 2.4% -41.8%
ACAD $51.53 2.1% 209.5%
ACER $3.64 1.7% -83.0%
ACHN $6.17 0.3% 266.3%
ACHV $0.91 -5.2% -28.9%
ACIU $8.73 6.6% -14.6%
ACOR $1.71 0.6% -89.5%
ACRS $1.66 2.5% -78.3%
ACST $1.86 -2.1% 106.7%
ADAP $1.10 -3.5% -80.1%
ADIL $1.54 11.6% -76.3%
ADMA $4.27 3.4% 63.0%
ADRO $1.16 -1.7% -57.5%
ADVM $11.45 8.5% 235.8%
ADXS $0.78 23.8% -82.4%
AEZS $0.86 -1.2% -71.6%
AFMD $2.30 -0.4% -28.6%
AGEN $3.92 -3.7% 56.2%
AGIO $40.71 1.6% -13.8%
AGLE $7.88 1.8% -2.0%
AGTC $2.90 -2.7% 9.4%
AIMT $29.59 1.6% 21.6%
AKAO $0.00 0.0% -100.0%
AKBA $5.87 -3.1% 1.2%
AKCA $17.67 0.3% -42.5%
AKTX $1.96 -1.0% 17.4%
ALBO $20.94 -2.2% -13.2%
ALDR $18.88 -0.2% 72.9%
ALDX $4.78 -1.0% -43.8%
ALKS $20.99 1.7% -27.9%
ALLK $117.77 -4.3% 126.5%
ALLO $31.39 6.3% 13.9%
ALNA $1.90 -2.6% -70.5%
ALNY $123.50 -0.6% 69.7%
ALPN $3.07 3.4% -24.9%
ALRN $0.50 3.4% -51.0%
ALT $1.89 3.3% -27.3%
AMAG $11.01 2.8% -30.1%
AMRN $22.45 2.9% 68.2%
ANAB $14.10 -0.9% -77.9%
ANIK $57.68 1.1% 67.1%
ANIP $59.32 1.1% 29.6%
APLS $24.00 -7.2% 76.2%
APOP $2.64 0.8% 14.3%
APRI $6.60 -2.9% -9.0%
APTO $2.54 -1.2% 15.5%
APTX $4.15 4.0% -75.9%
APVO $0.61 3.4% -57.0%
AQB $2.22 3.7% -7.1%
AQST $8.03 -3.7% 11.8%
ARAV $10.64 -7.3% 192.3%
ARCT $10.86 10.6% 131.6%
ARDS $5.46 4.2% -48.0%
ARDX $6.48 -4.7% 224.0%
ARGX $146.66 -2.0% 48.4%
ARNA $48.23 3.7% 19.9%
ARPO $0.56 -5.1% -71.9%
ARQL $9.70 2.0% 235.6%
ARRY $0.00 0.0% -100.0%
ARVN $38.39 1.7% 178.0%
ARWR $67.19 2.5% 412.1%
ASLN $2.39 -4.0% -42.4%
ASMB $16.61 3.8% -27.9%
ASND $108.16 -1.5% 66.8%
ASNS $3.11 -4.0% 21.5%
ATHX $1.33 2.3% -10.1%
ATNX $17.31 5.3% 35.6%
ATRA $13.99 2.3% -60.3%
AUPH $15.40 2.7% 125.2%
AUTL $14.84 0.4% -55.5%
AVDL $6.24 8.3% 124.5%
AVEO $0.76 0.0% -58.5%
AVRO $17.85 0.5% 14.1%
AVXL $2.69 -7.6% 60.1%
AXON $1.22 -5.4% 11.9%
AXSM $44.93 3.9% 1,576.5%
AYTU $0.73 -8.8% -8.8%
AZRX $0.76 1.3% -41.5%
BCLI $3.94 -0.5% 13.9%
BCRX $2.70 3.9% -68.2%
BDSI $6.50 0.2% 78.1%
BFRA $10.14 -2.6% -13.4%
BGNE $186.44 -1.5% 37.1%
BHVN $54.40 1.2% 48.3%
BLCM $0.81 0.0% -75.7%
BLPH $0.43 7.5% -51.1%
BLRX $2.29 12.3% -69.5%
BLUE $79.32 -1.7% -20.3%
BOLD $59.24 0.1% 166.7%
BPMC $78.32 5.0% 53.0%
BSTC $55.73 1.5% -7.1%
BTAI $6.50 2.4% 86.3%
BVXV $5.77 1.6% 19.7%
BYSI $14.00 2.3% -24.5%
CALA $4.64 5.0% 9.7%
CAPR $1.30 -17.7% -73.7%
CARA $16.78 4.0% 15.3%
CASI $3.20 0.3% -19.0%
CATB $5.86 -0.3% 32.3%
CBAY $1.76 6.0% -78.7%
CBIO $5.25 4.2% -36.4%
CBLI $0.67 -9.5% -46.0%
CBM $59.99 0.0% 55.3%
CBMG $17.45 0.2% -6.6%
CBPO $116.65 0.0% 57.7%
CCXI $31.34 0.9% 183.1%
CDMO $5.78 2.1% 35.4%
CDMOP $26.50 0.2% 4.7%
CDTX $2.65 6.0% -1.9%
CDXC $3.80 1.6% 11.4%
CDXS $15.53 1.4% -3.6%
CERC $3.85 14.2% 10.3%
CERS $4.10 0.5% -23.2%
CFRX $0.33 -5.7% -81.5%
CGEN $5.35 -0.7% 127.7%
CHMA $5.28 -0.4% 77.2%
CHRS $18.16 3.4% 99.1%
CKPT $1.26 4.1% -40.3%
CLBS $2.58 0.0% -36.8%
CLDX $2.57 0.4% -31.7%
CLGN $4.97 0.4% 8.3%
CLLS $14.69 0.9% -14.4%
CLRB $1.90 -2.6% 20.3%
CLSD $1.66 2.5% 44.4%
CLSN $1.47 2.8% -12.0%
CLVS $9.48 7.0% -51.1%
CMRX $2.42 2.1% -9.7%
CNAT $0.38 0.0% -79.0%
CNCE $7.37 -0.5% -45.7%
CNST $42.33 -0.8% 866.4%
CO $4.50 0.2% -27.4%
COCP $0.53 0.0% -86.0%
CORI $12.68 0.2% -82.4%
CORT $13.24 1.1% -4.2%
CRBP $5.13 3.6% -21.7%
CRIS $1.61 -12.5% 96.3%
CRNX $20.32 1.4% -30.7%
CRSP $72.48 2.5% 142.7%
CRVS $4.41 -3.3% 3.3%
CSBR $7.77 6.3% -19.6%
CTIC $0.94 -2.0% 1.1%
CTMX $6.29 2.6% -59.7%
CTRV $0.00 0.0% -100.0%
CTXR $0.47 0.0% -56.5%
CUE $11.71 3.4% 126.9%
CUR $1.52 -16.9% -76.9%
CWBR $1.70 1.8% -50.3%
CYAD $12.68 5.1% -35.8%
CYCC $0.59 11.3% -14.5%
CYTK $9.42 -4.1% 38.1%
CYTR $0.43 38.7% -17.3%
CYTX $0.00 0.0% -100.0%
DARE $0.83 1.2% 12.2%
DBVT $7.85 0.7% 13.3%
DCPH $52.70 2.6% 134.4%
DERM $7.89 0.0% 7.1%
DFFN $0.48 2.1% -77.1%
DMPI $0.63 8.6% -82.1%
DNLI $18.24 0.3% -5.6%
DOVA $28.04 0.1% 220.8%
DRNA $26.58 0.3% 125.8%
DVAX $5.70 0.2% -39.7%
EARS $1.39 -2.1% -84.7%
EBS $54.85 4.3% -4.9%
ECYT $23.99 0.0% -42.8%
EDGE $0.50 11.1% 38.9%
EDIT $30.91 1.7% 32.4%
EIDX $59.48 1.4% 324.0%
EIGR $13.18 1.5% 27.8%
ELOX $5.16 -10.0% -20.5%
ENTA $64.18 1.9% -11.3%
EPZM $18.18 18.8% 172.6%
EQ $3.95 -3.9% -46.8%
ERYP $4.33 -11.8% -38.2%
ESPR $49.63 5.6% 8.6%
ETON $6.04 1.0% -1.0%
ETTX $4.90 -1.6% 8.7%
EVFM $6.90 7.6% 66.3%
EVLO $4.29 -4.7% -68.1%
EXEL $17.43 1.6% -12.5%
EYEG $6.94 -0.3% -1.6%
EYEN $3.56 -4.0% 18.7%
EYPT $1.51 2.7% -22.6%
FATE $13.75 1.3% 1.6%
FBIO $2.08 -2.8% 90.8%
FENC $6.27 0.0% -3.8%
FGEN $46.79 -0.7% 2.1%
FIXX $17.99 1.2% -26.6%
FLKS $0.00 0.0% -100.0%
FOLD $10.09 0.7% 0.5%
FOMX $3.05 2.0% -15.8%
FPRX $3.86 2.4% -58.8%
FTSV $14.01 -0.9% -10.7%
FWP $5.69 585.5% 546.6%
GBT $79.10 3.9% 92.3%
GEMP $0.30 -9.1% -63.0%
GERN $1.51 -0.7% 45.2%
GLMD $6.43 -2.7% -15.4%
GLPG $213.58 1.9% 136.0%
GLYC $6.00 2.0% -40.1%
GMDA $5.10 0.2% -51.5%
GNCA $2.18 0.9% -35.1%
GNMX $0.14 0.0% -81.8%
GNPX $0.30 0.0% -78.6%
GRFS $22.99 2.7% 27.4%
GRTS $9.03 7.2% -44.6%
GTHX $22.62 10.1% 15.6%
GTXI $0.00 0.0% -100.0%
HALO $19.16 0.5% 29.5%
HSGX $0.16 -30.4% 33.3%
HTBX $0.46 2.2% -56.6%
ICPT $108.91 -9.1% 12.0%
IDRA $1.81 3.4% -48.0%
IFRX $3.20 -1.8% -90.8%
IMGN $3.88 -0.3% -18.8%
IMMP $1.73 1.8% -15.2%
IMMU $20.51 10.9% 36.9%
IMV $2.83 -0.7% -44.7%
INFI $1.24 -0.8% -0.8%
INNT $0.73 1.4% -68.8%
INO $2.39 2.6% -43.4%
INSM $23.13 2.5% 65.6%
INSY $0.00 0.0% -100.0%
INVA $12.91 -0.5% -25.4%
IONS $64.53 0.0% 20.0%
IOVA $24.71 -0.6% 161.5%
IPCI $0.21 -22.2% -19.2%
ITCI $10.24 4.4% -11.1%
ITRM $3.25 -8.5% -43.5%
JAGX $0.58 -4.9% -96.9%
JAZZ $149.81 1.2% 19.7%
JNCE $7.69 1.1% 98.7%
KALA $4.01 0.5% -22.7%
KALV $14.26 1.0% -28.7%
KDMN $4.44 8.6% 96.5%
KERX $3.36 -2.0% -80.8%
KIN $7.75 2.0% -29.2%
KMDA $7.36 -0.5% 43.8%
KMPH $0.38 -7.3% -80.8%
KNSA $10.54 5.7% -60.4%
KOD $64.00 -0.6% 771.9%
KRYS $61.99 3.5% 171.4%
KTOV $0.72 0.0% -4.0%
KURA $15.68 3.1% 9.3%
KZR $2.68 1.1% -88.2%
LGND $108.00 2.9% -21.2%
LIFE $4.46 0.5% -39.9%
LJPC $3.31 8.2% -66.9%
LOGC $7.64 0.5% -23.6%
LOXO $234.66 0.0% 67.9%
LPTX $0.81 2.5% -66.8%
LQDA $4.08 -0.7% -79.8%
LXRX $4.85 14.7% -29.8%
MACK $4.25 -2.8% 4.7%
MBIO $3.85 0.5% 27.5%
MBRX $1.03 1.0% -8.0%
MCRB $3.66 -0.5% -24.2%
MDGL $116.56 2.1% 4.8%
MDWD $2.89 5.5% -32.2%
MESO $6.69 -0.5% 49.0%
MGNX $9.61 3.8% -24.1%
MGTA $12.93 -0.4% 115.5%
MGTX $21.25 6.5% 116.2%
MLNT $1.77 11.3% -67.2%
MNKD $1.22 2.5% 3.4%
MNLO $4.36 5.6% -9.7%
MNOV $7.99 2.0% -2.6%
MOR $32.87 1.4% 28.0%
MRKR $3.05 -2.2% -50.9%
MRNS $1.33 5.6% -56.1%
MRSN $4.18 0.5% -3.0%
MRTX $102.42 -2.3% 129.4%
MRUS $16.29 -2.2% 13.9%
MTEM $12.12 2.4% 187.2%
MTFB $0.12 0.0% -98.4%
MTP $0.59 2.8% -69.5%
MYOK $67.00 -0.2% 59.7%
MYOV $16.46 -1.9% -2.8%
NBIX $116.59 0.1% 66.3%
NBRV $1.79 -4.3% 6.6%
NCNA $7.03 2.5% -52.4%
NERV $6.24 1.6% -9.8%
NITE $0.00 0.0% -100.0%
NK $1.58 5.3% 21.5%
NLNK $1.54 -1.9% -7.2%
NOVN $2.17 1.9% 121.4%
NSTG $26.39 0.2% 72.8%
NTEC $0.61 0.0% -92.4%
NTGN $1.00 6.4% -80.2%
NTLA $17.14 -0.5% 25.1%
NTRP $1.15 -2.5% -69.2%
NVAX $4.35 -4.4% -89.0%
NVIV $0.16 6.7% -90.2%
NVLN $0.68 -2.9% -27.7%
NVO $56.70 -0.7% 21.2%
NVUS $0.54 3.9% -67.5%
NYMX $1.88 1.1% 19.8%
OBSV $4.53 5.1% -65.6%
OCUL $4.32 3.4% 5.4%
ODT $30.28 -9.5% 112.5%
OHRP $0.00 0.0% -100.0%
OMED $0.00 0.0% -100.0%
OMER $13.20 -0.8% 11.4%
ONCE $110.49 0.7% 182.5%
ONCS $2.25 1.8% -65.7%
ONCY $1.14 0.0% -45.5%
ONS $0.65 1.6% -98.1%
ONTX $0.35 20.7% -85.6%
OPNT $13.75 2.1% -4.8%
ORGS $2.69 3.1% -46.1%
ORMP $4.60 -1.5% 36.9%
ORPN $11.50 6.7% 69.1%
ORTX $12.09 5.3% -19.3%
OSMT $6.47 -1.7% -16.8%
OTIC $2.51 -0.4% 32.8%
OVAS $0.69 -6.8% -98.1%
OVID $4.03 1.0% 49.3%
PBYI $7.98 7.3% -63.2%
PDLI $2.96 -1.0% 1.7%
PETX $0.00 0.0% -100.0%
PGNX $5.11 2.4% 20.2%
PHAS $3.32 2.8% 5.7%
PIRS $3.41 -0.6% 16.8%
PLXP $4.54 0.7% 121.5%
PRAN $1.68 1.8% -12.5%
PRNB $37.61 3.3% 31.3%
PRQR $8.27 3.8% -52.7%
PRTA $12.78 3.0% 21.7%
PRTK $3.07 2.3% -44.9%
PRTO $0.29 5.0% -88.2%
PRVB $11.06 -1.9% 461.4%
PSTI $3.80 0.5% -57.2%
PTCT $49.43 0.0% 47.1%
PTE $2.85 10.0% -81.0%
PTGX $7.69 0.7% 11.6%
PTI $3.50 -7.7% 0.9%
PTLA $29.13 2.8% 55.2%
PULM $0.87 3.6% -67.8%
QTRX $25.22 1.5% 38.3%
QURE $65.59 1.6% 129.9%
RARE $42.88 0.2% 2.8%
RARX $46.90 0.2% 114.2%
RCKT $22.10 12.1% 46.4%
RCUS $8.28 6.3% -22.5%
RDHL $6.54 0.3% 6.3%
REPH $16.50 1.5% 122.7%
REPL $13.86 2.9% 32.0%
RETA $197.98 -0.8% 255.3%
RGEN $90.14 2.0% 74.4%
RGLS $0.78 2.6% -29.7%
RGNX $44.75 2.8% 3.3%
RIGL $2.17 6.4% -8.1%
RLM $0.00 0.0% -100.0%
RTTR $0.20 5.3% -76.2%
RUBY $10.39 0.5% -42.6%
RVNC $16.36 2.7% -16.2%
RYTM $24.36 2.1% -10.6%
SAGE $64.25 6.8% -28.2%
SBBP $1.82 2.8% -59.0%
SBOT $1.05 -7.1% 2.9%
SBPH $3.51 1.7% -68.0%
SCPH $4.33 -1.1% 12.2%
SELB $1.52 2.0% -47.6%
SESN $1.19 -0.8% -19.1%
SGEN $117.25 0.1% 104.0%
SGMO $11.66 0.5% -1.0%
SIGA $4.47 -1.5% -41.1%
SLGL $8.65 -3.6% 36.2%
SLS $4.07 -4.9% 188.7%
SNDX $8.72 -1.0% 96.0%
SNGX $1.18 11.3% 22.9%
SNNA $0.21 -8.7% -91.6%
SNSS $0.32 -8.6% -27.3%
SPHS $0.36 2.9% -59.6%
SPPI $9.73 2.4% 5.4%
SPRO $11.98 4.8% 91.4%
SRNE $3.48 6.8% 31.8%
SRPT $109.36 -0.6% 1.7%
SRRA $0.48 26.3% -62.8%
SRRK $8.45 5.8% -60.9%
STML $10.26 4.6% 4.0%
STRO $10.20 2.0% 1.1%
SURF $2.25 12.5% -48.3%
SVA $6.47 -0.3% -7.3%
SVRA $1.14 2.7% -88.2%
SYBX $2.33 1.8% -69.4%
SYRS $4.59 -1.1% -22.5%
TBIO $10.00 3.0% 33.5%
TBPH $21.06 0.3% -19.6%
TCON $3.16 3.6% 345.1%
TECH $219.92 1.0% 55.0%
TENX $1.20 -0.8% -3.2%
TGTX $7.18 -6.5% 66.6%
TLC $5.04 1.0% -17.4%
TLSA $2.69 -3.2% -62.1%
TNXP $1.05 -0.9% -53.1%
TOCA $0.64 3.2% -92.5%
TORC $1.24 2.5% -86.1%
TRIL $0.30 -3.2% -84.5%
TRPX $1.34 0.0% -62.0%
TRVN $0.70 -2.8% 27.3%
TSRO $74.96 0.0% 0.9%
TTNP $0.19 11.8% -86.2%
TTPH $2.26 -0.4% 85.3%
TYME $1.08 1.9% -68.1%
UBX $7.19 1.7% -56.8%
UMRX $0.70 4.5% -84.3%
URGN $32.48 5.7% -27.0%
UROV $12.51 0.1% 78.7%
UTHR $91.61 1.5% -14.9%
VBIV $0.86 6.2% -47.9%
VBLT $1.21 -3.2% 22.2%
VCEL $18.61 1.4% 4.9%
VCNX $4.91 -1.1% 16.9%
VCYT $29.49 -1.7% 145.8%
VICL $0.00 0.0% -100.0%
VKTX $7.30 4.9% -12.3%
VNDA $17.46 2.1% -35.4%
VRCA $13.83 1.6% 74.0%
VRNA $3.90 -3.0% -59.6%
VSTM $1.30 4.0% -64.0%
VTGN $0.44 2.3% -72.3%
VTL $0.22 -4.4% 4.8%
VTVT $1.50 0.0% -46.8%
VVUS $2.77 -0.7% 18.4%
VXRT $0.33 3.1% -83.3%
VYGR $13.98 1.9% 48.4%
WVE $32.26 -0.7% -21.3%
XBIO $1.37 9.6% -93.3%
XBIT $11.05 0.3% 114.6%
XENE $13.93 0.4% 108.5%
XERS $8.77 1.0% -49.9%
XLRN $49.88 2.5% 13.1%
XNCR $40.94 0.8% 14.4%
XOMA $25.50 4.9% 92.2%
XON $5.37 0.2% -24.9%
XTLB $1.30 0.8% -46.7%
YMAB $32.72 -0.8% 79.7%
ZEAL $31.21 0.5% 152.7%
ZFGN $0.82 1.2% -83.8%
ZIOP $5.16 1.4% 131.2%
ZLAB $41.13 -0.1% 84.4%
ZSAN $1.66 -2.9% -29.1%
ZYME $41.79 -0.3% 184.5%
ZYNE $5.63 -0.4% 51.3%
CTST $0.84 6.3% -83.8%
CRMD $6.17 0.7% -11.2%
XFOR $10.70 0.2% -30.3%
IMRN $4.00 1.3% -31.2%
PFNX $10.52 -0.9% 204.1%
CVM $7.83 0.9% 168.5%
MRNA $19.24 -6.8% 25.5%
OTLK $1.13 -8.1% -74.3%
HEXO $4.25 0.5% 10.7%
RNN $0.00 0.0% -100.0%
ALEC $19.76 1.9% 9.8%
GNLN $2.67 -7.3% -87.4%
ORGO $5.10 6.0% -62.1%

Schlumberger Ltd, Kraft Heinz, Macys Inc, PLDT Inc. Sponsored ADR & Macerich Co.


DexCom, Ceridian HCM Holding Inc, AppFolio Inc, White Mountains Insurance Group Ltd & Easterly Government Properties Inc.





Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy